Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results
Pilar Suñé, Josep María Suñé, José Bruno Montoro Ronsano
PLoS ONE · 2013 · 1,724 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Suñé, P., Suñé, J. M., & Ronsano, J. B. M. (2013). Positive outcomes influence the rate and time to publication, but not the impact factor of publications of clinical trial results. PLoS ONE, 8(1), e54583. https://doi.org/10.1371/journal.pone.0054583
In text: (Suñé et al., 2013)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
OBJECTIVES: Publication bias may affect the validity of evidence based medical decisions. The aim of this study is to assess whether research outcomes affect the dissemination of clinical trial findings, in terms of rate, time to publication, and impact factor of journal publications. METHODS AND FINDINGS: All drug-evaluating clinical trials submitted to and approved by a general hospital ethics committee between 1997 and 2004 were prospectively followed to analyze their fate and publication. Published articles were identified by searching Pubmed and other electronic databases. Clinical study final reports submitted to the ethics committee, final reports synopses available online and meeting abstracts were also considered as sources of study results. Study outcomes were classified as positive (when statistical significance favoring experimental drug was achieved), negative (when no statistical significance was achieved or it favored control drug) and descriptive (for non-controlled studies). Time to publication was defined as time from study closure to publication. A survival analysis was performed using a Cox regression model to analyze time to publication. Journal impact factors of identified publications were recorded. Publication rate was 48·4% (380/785). Study results were identified for 68·9% of all completed clinical trials (541/785). Publication rate was 84·9% (180/212) for studies with results classified as positive and 68·9% (128/186) for studies with results classified as negative (p<0·001). Median time to publication was 2·09 years (IC95 1·61-2·56) for studies with results classified as positive and 3·21 years (IC95 2·69-3·70) for studies with results classified as negative (hazard ratio 1·99 (IC95 1·55-2·55). No differences were found in publication impact factor between positive (median 6·308, interquartile range: 3·141-28·409) and negative result studies (median 8·266, interquartile range: 4·135-17·157). CONCLUSIONS: Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results. However, no differences have been found in terms of impact factor.
Related papers
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews2021
- The Measurement of Observer Agreement for Categorical Data1977
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement2009
- Bias in meta-analysis detected by a simple, graphical test1997
- Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups2007
Metadata from OpenAlex (CC0). Citations are generated from the published record.